Different infective forms trigger distinct immune response in experimental chagas disease

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Vieira, Paula Melo de Abreu ^a   Francisco, Amanda Fortes ^a   Machado, Evandro Marques de Meneses ^a   Nogueira, Nívia Carolina ^a   Fonseca, Kátia da Silva ^a   Reis, Alexandre Barbosa ^a   Teixeira Carvalho, Andrea ^b   Martins Filho, Olindo Assis ^b   Tafuri, Washington Luiz ^a   Carneiro, Cláudia Martins ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDITIS; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; EXPERIMENTAL MODEL; FEMALE; HOST PARASITE INTERACTION; IMMUNE RESPONSE; IMMUNOMODULATION; INOCULATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MONOCYTE; MOUSE; NONHUMAN; PARASITEMIA; T LYMPHOCYTE SUBPOPULATION; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; ANIMAL; DISEASE MODEL; IMMUNOLOGY; IMMUNOPHENOTYPING; LEUKOCYTE; METABOLISM; MYOCARDITIS; PARASITOLOGY; PATHOLOGY; SPLEEN; T LYMPHOCYTE; TIME;

ANIMALIA; MUS;

ANIMALS; CHAGAS DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HOST-PARASITE INTERACTIONS; IMMUNOPHENOTYPING; LEUKOCYTES; MICE; MYOCARDITIS; PARASITEMIA; SPLEEN; T-LYMPHOCYTES; TIME FACTORS; TRYPANOSOMA CRUZI;

EID: 84857871731     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032912     Document Type: Article

References (36)

1. Andrade LO, Andrews NW, (2005) The Trypanosoma cruzi-host-cell interplay: location, invasion, retention. Nat Rev Microbiol 3: 819-823.
2. Kollien AH, Schaub GA, (2000) The development of Trypanosoma cruzi in triatominae. Parasitol Today 16: 381-387.
3. Gascon J, Bern C, Pinazo MJ, (2010) Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop 115: 22-27.
4. Bern C, Montgomery SP, Katz L, Caglioti S, Stramer SL, (2008) Chagas disease and the US blood supply. Curr Opin Infect Dis 21: 476-482.
5. Ramirez MI, Ruiz Rde C, Araya JE, Da Silveira JF, Yoshida N, (1993) Involvement of the stage-specific 82-kilodalton adhesion molecule of Trypanosoma cruzi metacyclic trypomastigotes in host cell invasion. Infect Immun 61: 3636-3641.
6. Camargo MM, Almeida IC, Pereira ME, Fergunson MA, Travassos LR, et al. (1997a) Glycosylphosphatidylinisitolánchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J Immunol 158 (12): 5890-5901.
7. Camargo MM, Andrade AC, Almeida IC, Travassos LR, Gazzinelli RT, (1997b) Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma - primed macrophages. J Immunol 159: 6131-6139.
8. Almeida IC, Camargo MM, Procópio DO, Silva LS, Mehlert A, et al. (2000) Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J 19 (7): 1476-1485.
9. Zambrano-Villa S, Rosales-Borjas D, Carrero JC, Ortiz-Ortiz L, (2002) How protozoan parasites evade the immune response. Trends in Parasitology 18 (6): 272-278.
10. Carneiro CM, Martins-Filho OA, Reis AB, Veloso VM, Araujo FM, et al. (2007) Differential impact of metacyclic and blood trypomastigotes on parasitological, serological and phenotypic features triggered during acute Trypanosoma cruzi infection in dogs. Acta Trop 101: 120-129.
11. Coura-Vital W, Carneiro CM, Martins HR, de Lana M, Veloso VM, et al. (2008) Trypanosoma cruzi: immunoglobulin isotype profiles during the acute phase of canine experimental infection with metacyclic or blood trypomastigotes. Exp Parasitol 120: 269-274.
12. Ribeirao M, Pereira-Chioccola VL, Renia L, Augusto Fragata Filho A, Schenkman S, et al. (2000) Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase. Parasite Immunol 22: 49-53.
13. Abel LC, Rizzo LV, Ianni B, Albuquerque F, Bacal F, et al. (2001) Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun 17: 99-107.
14. Ferreira RC, Ianni BM, Abel LC, Buck P, Mady C, et al. (2003) Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz 98: 407-411.
15. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, et al. (2003) Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun 71: 1185-1193.
16. Talvani A, Rocha MO, Ribeiro AL, Correa-Oliveira R, Teixeira MM, (2004) Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease. J Infect Dis 189: 214-220.
17. Laucella SA, Postan M, Martin D, Hubby Fralish B, Albareda MC, et al. (2004) Frequency of interferon- gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 189: 909-918.
18. Souza PE, Rocha MO, Rocha-Vieira E, Menezes CA, Chaves AC, et al. (2004) Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect Immun 72: 5283-5291.
19. Sathler-Avelar R, Vitelli-Avelar DM, Massara RL, de Lana M, Pinto Dias JC, et al. (2008) Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern. Microbes Infect 10: 103-113.
20. Vitelli-Avelar DM, Sathler-Avelar R, Teixeira-Carvalho A, Pinto Dias JC, et al. (2008) Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease. Scand J Immunol 68 (5): 516-525.
21. Brener Z, Gazzinelli RT, (1997) Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol 114: 103-110.
22. Nakhle MC, de Menezes Mda C, Irulegui I, (1989) Eosinophil levels in the acute phase of experimental Chagas' disease. Rev Inst Med Trop Sao Paulo 31: 384-391.
23. Rowland SP.,(1984) Bone marrow eosinophil levels in Trypanosoma cruzi infected mice. J Parasitol 70: 2.
24. Nascentes GA, Meira WS, Lages-Silva E, Ramírez LE, (2010) Immunization of Mice with a Trypanosoma cruzi-Like Strain Isolated from a Bat: Predictive Factors for Involvement of Eosinophiles in Tissue Damage. Vector Borne Zoonotic Dis 10: 1-9.
25. de Meis J, Morrot A, Farias-de-Oliveira DA, Villa-Verde DM, Savino W, (2009) Differential regional immune response in Chagas disease. PLoS Negl Trop Dis 3: e417.
26. Sathler-Avelar R, Lemos EM, Reis DD, Medrano-Mercado N, Araujo-Jorge TC, et al. (2003) Phenotypic features of peripheral blood leucocytes during early stages of human infection with Trypanosoma cruzi. Scand J Immunol 58: 655-663.
27. Kroll-Palhares K, Silverio JC, Silva AA, Michailowsky V, Marino AP, et al. (2008) TNF/TNFR1 signaling up-regulates CCR5 expression by CD8+ T lymphocytes and promotes heart tissue damage during Trypanosoma cruzi infection: beneficial effects of TNF-alpha blockade. Mem Inst Oswaldo Cruz 103: 375-385.
28. Padilla AM, Bustamante JM, Tarleton RL, (2009) CD8+ T cells in Trypanosoma cruzi infection. Curr Opin Immunol 21: 385-390.
29. Reis MM, Higuchi Mde L, Benvenuti LA, Aiello VD, Gutierrez PS, et al. (1997) An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin Immunol Immunopathol 83: 165-172.
30. Tarleton RL, (1988) Tumour necrosis factor (cachectin) production during experimental Chagas' disease. Clin Exp Immunol 73: 186-190.
31. Truyens C, Torrico F, Lucas R, De Baetselier P, Buurman WA, et al. (1999) The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi. Infect Immun 67: 5579-5586.
32. Lima ES, Andrade ZA, Andrade SG, (2001) TNF-alpha is expressed at sites of parasite and tissue destruction in the spleen of mice acutely infected with Trypanosoma cruzi. Int J Exp Pathol 82: 327-336.
33. Andrade SG, Magalhaes Ldos A, Pessina DH, (2008) Importance of TNF-alpha in the course of acute infection with Trypanosoma cruzi: influence of its inhibition by pentoxifylline treatment. Mem Inst Oswaldo Cruz 103: 21-26.
34. Russo M, Starobinas N, Ribeiro-Dos-Santos R, Minoprio P, Eisen H, et al. (1989) Susceptible mice present higher macrophage activation than resistant mice during infections with myotropic strains of Trypanosoma cruzi. Parasite Immunol 11: 385-395.
35. Starobinas N, Russo M, Minoprio P, Hontebeyrie-Joskowicz M, (1991) Is TNF alpha involved in early susceptibility of Trypanosoma cruzi-infected C3H/He mice? Res Immunol 142: 117-122.
36. Reed SG, (1988) In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J Immunol 140: 4342-4347.